Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/104049
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaur, Palvinderen
dc.contributor.authorKhong, Wei Xinen
dc.contributor.authorWee, Sue Yuenen
dc.contributor.authorTan, Eng Leeen
dc.contributor.authorPipper, Juergenen
dc.contributor.authorKoay, Evelynen
dc.contributor.authorNg, Kah Yingen
dc.contributor.authorYap, Joe Kwanen
dc.contributor.authorChew, Kuan Kiaten
dc.contributor.authorTan, Mei Tingen
dc.contributor.authorLeo, Yee Sinen
dc.contributor.authorInoue, Masafumien
dc.contributor.authorNg, Oon Teken
dc.contributor.editorKumar, Anilen
dc.date.accessioned2014-06-02T01:58:38Zen
dc.date.accessioned2019-12-06T21:25:15Z-
dc.date.available2014-06-02T01:58:38Zen
dc.date.available2019-12-06T21:25:15Z-
dc.date.copyright2014en
dc.date.issued2014en
dc.identifier.citationKaur, P., Khong, W. X., Wee, S. Y., Tan, E. L., Pipper, J., Koay, E., et al. (2014). Clinical Evaluation of a Low Cost, In-House Developed Real-Time RT-PCR Human Immunodeficiency Virus Type 1 (HIV-1) Quantitation Assay for HIV-1 Infected Patients. PLoS ONE, 9(3).en
dc.identifier.issn1932-6203en
dc.identifier.urihttps://hdl.handle.net/10356/104049-
dc.description.abstractObjectives HIV-1 viral quantitation is essential for treatment monitoring. An in-house assay would decrease financial barriers to access. Materials and Methods A real-time competitive RT-PCR in house assay (Sing-IH) was developed in Singapore. Using HXB2 as reference, the assay's primers and probes were designed to generate a 183-bp product that overlaps a portion of the LTR region and gag region. A competitive internal control (IC) was included in each assay to monitor false negative results due to inhibition or human error. Clinical evaluation was performed on 249 HIV-1 positive patient samples in comparison with the commercially available Generic HIV Viral Load assay. Correlation and agreement of results were assessed for plasma HIV-1 quantification with both assays. Results The assay has a lower limit of detection equivalent to 126 copies/mL of HIV-1 RNA and a linear range of detection from 100–1000000 copies/mL. Comparative analysis with reference to the Generic assay demonstrated good agreement between both assays with a mean difference of 0.22 log10 copies/mL and 98.8% of values within 1 log10 copies/mL range. Furthermore, the Sing-IH assay can quantify HIV-1 group M subtypes A–H and group N isolates adequately, making it highly suitable for our region, where subtype B and CRF01_AE predominate. Conclusions With a significantly lower running cost compared to commercially available assays, the broadly sensitive Sing-IH assay could help to overcome the cost barriers and serve as a useful addition to the currently limited HIV viral load assay options for resource-limited settings.en
dc.language.isoenen
dc.relation.ispartofseriesPLoS ONEen
dc.rights© 2014 Kaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en
dc.subjectDRNTU::Science::Medicineen
dc.titleClinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patientsen
dc.typeJournal Articleen
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en
dc.identifier.doi10.1371/journal.pone.0089826en
dc.description.versionPublished versionen
item.fulltextWith Fulltext-
item.grantfulltextopen-
Appears in Collections:LKCMedicine Journal Articles

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.